Archive -Month: January 2022

Company’s Innovative Technology Increases Yield of High-Quality Saponin-Based Adjuvants, Enabling the Sustainable Supply of Billions of Doses...

Bruce Forrest recently joined the Q-VANT team as Chief Scientific Officer, bringing more than two decades of experience in vaccine and adjuvant...

The Quillaja saponaria tree is a slow-growing evergreen native to Chile whose bark has long been used for medicinal and commercial purposes....

Q-VANT Biosciences launched recently as the first company to use a computational-driven approach to solve the supply chain problem of QS-21 and...